Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T14:16:35.647Z.
Calculation as of: 2026-10-06T14:16:35.647Z.
Quote observation: 2026-10-06T14:15:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 53665e9507d83c8b512d12f732f84b3e68684f2a8a74f2f2c17a75b00a061e9e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-03-25.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$90.38M
EV/FCF Ratio
22.29x
TTM Avg
56.27x
3Y Avg
59.65x
5Y Avg
59.65x
Market Cap
$86.32M
EV/FCF Ratio
N/A
TTM Avg
17.26x
3Y Avg
15.52x
5Y Avg
17.05x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Equillium, Inc. (EQ) | $88.52M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $90.38M | 22.29x | 56.27x | 59.65x | 59.65x |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 5.88x | 5.69x | 5.19x | 9.05x |
| Biomea Fusion, Inc. (BMEA)vs › | $90.74M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $92.14M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $86.32M | N/A | 17.26x | 15.52x | 17.05x |
| Conexeu Sciences Inc. (CNXU)vs › | $84.29M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.97M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.59M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.04M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-03-25 | 4.46x |
| 2024-03-22 | 5.60x |
| 2024-03-21 | 5.45x |
| 2024-03-20 | 5.78x |
| 2024-03-19 | 5.21x |
| 2024-03-18 | 5.06x |
| 2024-03-15 | 4.76x |
| 2024-03-14 | 4.79x |
| 2024-03-13 | 5.03x |
| 2024-03-12 | 4.73x |
| 2024-03-11 | 4.73x |
| 2024-03-08 | 5.15x |
| 2024-03-07 | 5.27x |
| 2024-03-06 | 3.91x |
| 2024-03-05 | 3.85x |
| 2024-03-04 | 3.82x |
| 2024-03-01 | 4.64x |
| 2024-02-29 | 4.61x |
| 2024-02-28 | 4.94x |
| 2024-02-27 | 4.64x |
| 2024-02-26 | 5.48x |
| 2024-02-23 | 4.76x |
| 2024-02-22 | 4.94x |
| 2024-02-21 | 4.64x |
| 2024-02-20 | 6.14x |
| 2024-02-16 | 5.42x |
| 2024-02-15 | 3.19x |
| 2024-02-14 | 1.93x |
| 2024-02-13 | 1.81x |
| 2024-02-12 | 2.17x |
| 2024-02-09 | 1.75x |
| 2024-02-08 | 1.69x |
| 2024-02-07 | 1.57x |
| 2024-02-06 | 0.81x |
| 2023-10-09 | 0.59x |
| 2023-10-06 | 1.22x |
| 2023-10-04 | 1.99x |
| 2023-10-03 | 0.53x |
| 2023-10-02 | 0.83x |
| 2023-09-29 | 2.00x |
| 2023-09-28 | 0.92x |
| 2023-09-27 | 0.84x |
| 2023-09-26 | 0.50x |
| 2023-09-25 | 2.77x |
| 2023-09-22 | 5.84x |
| 2023-09-21 | 6.53x |
| 2023-09-20 | 5.49x |
| 2023-09-19 | 6.89x |
| 2023-09-18 | 8.15x |
| 2023-09-15 | 8.92x |
| 2023-09-14 | 6.59x |
| 2023-09-13 | 5.09x |
| 2023-09-12 | 6.29x |
| 2023-09-11 | 6.61x |
| 2023-09-08 | 8.35x |
| 2023-09-07 | 7.76x |
| 2023-09-06 | 6.61x |
| 2023-09-05 | 8.15x |
| 2023-09-01 | 5.84x |
| 2023-08-31 | 7.38x |
| 2023-08-30 | 6.61x |
| 2023-08-29 | 6.61x |
| 2023-08-28 | 8.15x |
| 2023-08-25 | 8.92x |
| 2023-08-24 | 11.22x |
| 2023-08-23 | 11.22x |
| 2023-08-22 | 10.45x |
| 2023-08-21 | 9.68x |
| 2023-08-18 | 9.68x |
| 2023-08-17 | 9.68x |
| 2023-08-16 | 8.15x |
| 2023-08-15 | 2.00x |
| 2023-08-14 | 5.84x |
| 2023-08-11 | 7.38x |
| 2023-08-10 | 6.61x |
